Chemoinformaics analysis of 15-nor-Funebran-3-one
| Molecular Weight | 206.329 | nRot | 0 |
| Heavy Atom Molecular Weight | 184.153 | nRig | 14 |
| Exact Molecular Weight | 206.167 | nRing | 3 |
| Solubility: LogS | -3.729 | nHRing | 0 |
| Solubility: LogP | 3.368 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 38.8514 |
| nHD | 0 | BPOL | 22.9386 |
| QED | 0.593 |
| Synth | 5.258 |
| Natural Product Likeliness | 3.045 |
| NR-PPAR-gamma | 0.053 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.036 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.719 |
| MDCK | 0.0000209 |
| BBB | 0.932 |
| PPB | 0.847242 |
| VDSS | 1.18 |
| FU | 0.170081 |
| CYP1A2-inh | 0.093 |
| CYP1A2-sub | 0.381 |
| CYP2c19-inh | 0.134 |
| CYP2c19-sub | 0.875 |
| CYP2c9-inh | 0.323 |
| CYP2c9-sub | 0.691 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.833 |
| CYP3a4-inh | 0.068 |
| CYP3a4-sub | 0.218 |
| CL | 15.597 |
| T12 | 0.265 |
| hERG | 0.007 |
| Ames | 0.013 |
| ROA | 0.322 |
| SkinSen | 0.046 |
| Carcinogencity | 0.03 |
| EI | 0.611 |
| Respiratory | 0.769 |
| NR-Aromatase | 0.018 |
| Antiviral | Yes |
| Prediction | 0.854764 |